RT Book, Section A1 Cook, Kristen A2 DiPiro, Joseph T. A2 Talbert, Robert L. A2 Yee, Gary C. A2 Matzke, Gary R. A2 Wells, Barbara G. A2 Posey, L. Michael SR Print(0) ID 1148579537 T1 Anemias T2 Pharmacotherapy: A Pathophysiologic Approach, 10e YR 2017 FD 2017 PB McGraw-Hill Education PP New York, NY SN 9781259587481 LK accesspharmacy.mhmedical.com/content.aspx?aid=1148579537 RD 2024/04/24 AB Patient Care Process for the Management of AnemiaCollectPatient characteristics (e.g., age, race, sex, pregnant)Patient history (past medical, dietary habits, activity)Symptoms of anemia (fatigue, weakness, chest pain, dizziness, paleness, etc. (see Clinical Presentation Box 100-1)Current medications (including over-the-counter and supplements)Objective data (see Box 100-1)Blood pressure (BP), heart rate (HR)Labs (CBC, iron studies, vitamin B12, foliate, homocysteine, MMA, etc.)AssessUnderlying disease states (blood loss, heart failure, chronic renal disease, HIV, malignancy; see Table 100-6)Dietary habits and potential social factors contributing to nutritional deficienciesAcuity of symptoms and need for transfusion or hospitalizationCurrent medications that may contribute to or worsen anemia or blood lossLab results to determine underlying etiology of anemia for proper treatment selection or attainment of treatment goalsPlan*Dietary interventions for nutritional deficiencies (Tables 100-1, 100-4, 100-5)Initiate proper drug therapy treatment based on etiology. This includes correct formulation, strength, dosing, frequency, pertinent drug interactions. (Table 100-2 and 100-3 for iron product selection/drug interactions)Monitoring for efficacy and safety (lab and symptom improvement, corrected etiology if possible, adverse effects)Patient education (expectations/purpose of treatment, adverse effects, diet, etc.)Improved treatment of underlying pathologies if contributing to anemia of chronic diseaseImplement*Educate patient on treatment interventions and treatment expectationsReinforce adherence to treatment plan for short and long term successSchedule patient for follow-up at appropriate intervalsFollow-up: Monitor and EvaluateRecheck lab values within 4 weeks after treatment initiationTolerability of medications (e.g., adverse effects)Symptom improvementIf minimal improvement or worsening, evaluate whether etiology of anemia is correct*Collaborate with patient, caregivers, and other health professionals